Moderna (MRNA) has had the highest return since January 1, 2026 by a US stock in the Biotechnology Industry, returning 733.7%.
| ASSET | % RETURN |
|---|---|
Moderna (MRNA) | 733.69% |
Adlai Nortye Ltd American Depositary Shares (ANL) | 664.08% |
Avita Medical (RCEL) | 395.7% |
Veradermics (MANE) | 360.47% |
CareDx (CDNA) | 330.84% |
Erasca (ERAS) | 325.34% |
First Tracks Biotherapeutics (TRAX) | 300.4% |
AN2 Therapeutics (ANTX) | 298.21% |
Kodiak Sciences (KOD) | 291.76% |
Twist Bioscience (TWST) | 286.35% |
Oruka Therapeutics (ORKA) | 253.58% |
Abcellera Biologics (ABCL) | 249.42% |
Spyre Therapeutics (SYRE) | 226.07% |
Silence Therapeutics (SLN) | 219.87% |
Immunitybio (IBRX) | 200.5% |
Climb Bio (CLYM) | 198.78% |
Iovance Biotherapeutics (IOVA) | 191.01% |
Tango Therapeutics (TNGX) | 190.73% |
Rallybio (RLYB) | 186.23% |
Absci (ABSI) | 185.07% |
Alpha Tau Medical (DRTS) | 180.4% |
Q32 Bio (QTTB) | 178.79% |
OmniAb (OABI) | 175.68% |
Nuvectis Pharma (NVCT) | 163.41% |
Xencor (XNCR) | 161.07% |